Multimodality Imaging of Prostate Cancer.

Aged Antigens, Surface / metabolism Carboxylic Acids / chemistry Choline / chemistry Cyclobutanes / chemistry Disease Progression Fluorodeoxyglucose F18 / chemistry Glutamate Carboxypeptidase II / metabolism Humans Magnetic Resonance Imaging Male Middle Aged Multimodal Imaging / methods Multiparametric Magnetic Resonance Imaging Neoplasm Metastasis Neoplasm Recurrence, Local / pathology Neoplasm Staging Positron Emission Tomography Computed Tomography Positron-Emission Tomography Prostatic Neoplasms / diagnostic imaging Prostatic Neoplasms, Castration-Resistant / diagnostic imaging Radionuclide Imaging Theranostic Nanomedicine Tomography, X-Ray Computed Whole Body Imaging
PET/MRI PSMA fluciclovine multiparametric MRI theranostics whole-body MRI

Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
10 2019
Historique:
received: 27 06 2019
accepted: 29 08 2019
pubmed: 5 9 2019
medline: 14 4 2020
entrez: 5 9 2019
Statut: ppublish

Résumé

Prostate cancer is a very heterogeneous disease, and contemporary management is focused on identification and treatment of the prognostically adverse high-risk tumors while minimizing overtreatment of indolent, low-risk tumors. In recent years, imaging has gained increasing importance in the detection, staging, posttreatment assessment, and detection of recurrence of prostate cancer. Several imaging modalities including conventional and functional methods are used in different clinical scenarios with their very own advantages and limitations. This continuing medical education article provides an overview of available imaging modalities currently in use for prostate cancer followed by a more specific section on the value of these different imaging modalities in distinct clinical scenarios, ranging from initial diagnosis to advanced, metastatic castration-resistant prostate cancer. In addition to established imaging indications, we will highlight some potential future applications of contemporary imaging modalities in prostate cancer.

Identifiants

DOI: 10.2967/jnumed.119.228320 PMID: 31481573 PMC: PMC6785785
pubmed: 31481573
pii: jnumed.119.228320
doi: 10.2967/jnumed.119.228320
pmc: PMC6785785
doi:

Substances chimiques

Antigens, Surface 0
Carboxylic Acids 0
Cyclobutanes 0
Fluorodeoxyglucose F18 0Z5B2CJX4D
fluciclovine F-18 38R1Q0L1ZE
FOLH1 protein, human EC 3.4.17.21
Glutamate Carboxypeptidase II EC 3.4.17.21
Choline N91BDP6H0X

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1350-1358

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Informations de copyright

© 2019 by the Society of Nuclear Medicine and Molecular Imaging.

Références

Clin Cancer Res. 2018 Dec 15;24(24):6300-6307
pubmed: 30139879
Urol Oncol. 2018 Aug;36(8):349-360
pubmed: 29887240
Eur Urol Focus. 2017 Apr;3(2-3):223-239
pubmed: 28753774
Eur Urol. 2013 Jun;63(6):1040-8
pubmed: 23036576
Eur J Nucl Med Mol Imaging. 2018 Oct;45(11):1884-1897
pubmed: 29876619
Clin Oncol (R Coll Radiol). 2013 Apr;25(4):252-64
pubmed: 23313568
J Urol. 2011 Mar;185(3):869-75
pubmed: 21239008
J Nucl Med. 2019 Jul;60(7):971-977
pubmed: 30683768
BJU Int. 2018 Nov;122(5):783-793
pubmed: 29726071
Radiology. 2018 Jan;286(1):186-195
pubmed: 29053402
J Nucl Med. 2004 Sep;45(9):1509-18
pubmed: 15347718
Eur Urol Focus. 2016 Dec;2(5):506-513
pubmed: 28723516
Radiology. 2018 Aug;288(2):495-505
pubmed: 29786490
J Nucl Med. 2017 Apr;58(4):14N-17N
pubmed: 28373397
J Nucl Med. 2016 Oct;57(Suppl 3):73S-78S
pubmed: 27694177
Eur Urol. 2017 Jan;71(1):81-92
pubmed: 27317091
Eur Rev Med Pharmacol Sci. 2016 Sep;20(18):3770-3776
pubmed: 27735042
J Clin Oncol. 2016 Apr 20;34(12):1402-18
pubmed: 26903579
J Nucl Med. 2018 Jul 12;:null
pubmed: 30002112
Lancet. 2017 Feb 25;389(10071):815-822
pubmed: 28110982
J Urol. 2019 Feb;201(2):322-331
pubmed: 30179618
Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):496-508
pubmed: 29247284
J Nucl Med. 2018 Oct;59(10):1516-1523
pubmed: 29626121
Am J Surg Pathol. 2012 Sep;36(9):1346-52
pubmed: 22531173
J Urol. 2016 May;195(5):1436-1443
pubmed: 26682756
Eur Urol. 2016 Aug;70(2):233-45
pubmed: 26215604
Eur Radiol. 2011 Sep;21(9):1970-8
pubmed: 21533634
Eur Urol Focus. 2019 Jul;5(4):550-560
pubmed: 29133278
Eur Radiol. 2018 Aug;28(8):3151-3159
pubmed: 29294158
Radiology. 2006 Mar;238(3):929-37
pubmed: 16424250
Eur J Nucl Med Mol Imaging. 2015 Nov;42(12):1794-800
pubmed: 26162799
Eur Urol. 2017 Aug;72(2):250-266
pubmed: 28336078
J Clin Imaging Sci. 2016 Apr 29;6:18
pubmed: 27195184
J Urol. 2011 Nov;186(5):1818-24
pubmed: 21944089
Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2114-2121
pubmed: 27290607
Cancer J. 2013 Jan-Feb;19(1):43-9
pubmed: 23337756
Theranostics. 2012;2(3):318-30
pubmed: 22448198
Radiology. 2013 Aug;268(2):440-50
pubmed: 23481164
Eur Urol. 2019 Sep;76(3):340-351
pubmed: 30898406
Sci Rep. 2018 Mar 9;8(1):4254
pubmed: 29523813
Radiographics. 2016 Jan-Feb;36(1):142-59
pubmed: 26587888
J Nucl Med. 2017 Nov;58(11):1778-1785
pubmed: 28798033
Eur Urol. 2012 Mar;61(3):480-7
pubmed: 22078338
Radiology. 2014 Apr;271(1):220-9
pubmed: 24475817
Clin Radiol. 2008 Apr;63(4):387-95
pubmed: 18325358
Oncotarget. 2018 Jan 4;9(11):9867-9874
pubmed: 29515776
AJR Am J Roentgenol. 2018 Mar;210(3):W95-W109
pubmed: 29381380
Radiology. 2018 Dec;289(3):730-737
pubmed: 30226456
JAMA Oncol. 2018 Jul 1;4(7):944-951
pubmed: 29799999
J Nucl Med. 2017 Jan;58(1):85-90
pubmed: 27765862
J Nucl Med. 2019 Mar;60(3):362-368
pubmed: 30042163
N Engl J Med. 2018 May 10;378(19):1767-1777
pubmed: 29552975
J Urol. 2019 Aug;202(2):231-240
pubmed: 30829130
N Engl J Med. 2015 Aug 20;373(8):737-46
pubmed: 26244877
Clin Cancer Res. 1999 Oct;5(10):2674-81
pubmed: 10537328
J Nucl Med. 2017 Aug;58(8):1196-1200
pubmed: 28663195
Cancer. 1998 Jun 1;82(11):2256-61
pubmed: 9610707
Eur J Nucl Med Mol Imaging. 2014 Jan;41(1):11-20
pubmed: 24072344
J Nucl Med. 2004 Mar;45(3):366-73
pubmed: 15001675
Lancet Oncol. 2018 Dec;19(12):e696-e708
pubmed: 30507436
Eur Urol. 2017 Apr;71(4):618-629
pubmed: 27568654
J Nucl Med. 2019 Sep;60(9):1253-1258
pubmed: 30902875
Eur J Nucl Med Mol Imaging. 2017 May;44(5):776-787
pubmed: 27988802
Lancet Oncol. 2018 Jun;19(6):825-833
pubmed: 29752180
Radiology. 2011 Jun;259(3):852-61
pubmed: 21493787
Eur Urol. 2016 Nov;70(5):829-836
pubmed: 26795686
JAMA Oncol. 2019 Jun 1;5(6):856-863
pubmed: 30920593
Eur Urol. 2014 Feb;65(2):270-273
pubmed: 24295792
Korean J Radiol. 2018 Sep-Oct;19(5):819-831
pubmed: 30174470
Eur Urol. 2014 Sep;66(3):479-86
pubmed: 24345725
J Nucl Med. 2019 Aug;60(8):1118-1123
pubmed: 30683764
Semin Nucl Med. 2016 Nov;46(6):502-506
pubmed: 27825430
J Nucl Med. 2010 Nov;51(11):1813-20
pubmed: 21051652
JAMA Oncol. 2018 Feb 1;4(2):217-224
pubmed: 29121144
Abdom Radiol (NY). 2019 Mar;44(3):1052-1061
pubmed: 30460528
Radiol Oncol. 2011 Mar;45(1):17-21
pubmed: 22933929
Eur Urol. 2016 Jan;69(1):16-40
pubmed: 26427566

Auteurs

Soleen Ghafoor (S)

Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; and ghafoors@mskcc.org.

Irene A Burger (IA)

Department of Nuclear Medicine, Baden Cantonal Hospital, Baden, Switzerland.

Alberto H Vargas (AH)

Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; and.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

Recherchemedicale.com › Personnes › Tranches d'âge › Adulte › Sujet âgé › Multimodality Imaging of Prostate Cancer.
Recherchemedicale.com › Facteurs biologiques › Antigènes › Antigènes de surface › Multimodality Imaging of Prostate Cancer.
Recherchemedicale.com › Composés chimiques organiques › Acides carboxyliques › Multimodality Imaging of Prostate Cancer.
Recherchemedicale.com › Composés chimiques organiques › Composés onium › Composés d'ammonium quaternaire › Choline › Multimodality Imaging of Prostate Cancer.
Recherchemedicale.com › Composés chimiques organiques › Hydrocarbures › Hydrocarbures cycliques › Hydrocarbures alicycliques › Cyclobutanes › Multimodality Imaging of Prostate Cancer.
Recherchemedicale.com › États, signes et symptômes pathologiques › Processus pathologiques › Caractéristiques de la maladie › Évolution de la maladie › Multimodality Imaging of Prostate Cancer.
Recherchemedicale.com › Glucides › Désoses › Désoxyglucose › Fluorodésoxyglucose F18 › Multimodality Imaging of Prostate Cancer.
Recherchemedicale.com › Enzymes et coenzymes › Enzymes › Hydrolases › Peptide hydrolases › Metalloproteases › Metalloexopeptidases › Glutamate carboxypeptidase II › Multimodality Imaging of Prostate Cancer.
Recherchemedicale.com › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Multimodality Imaging of Prostate Cancer.
Recherchemedicale.com › Diagnostic › Techniques et procédures diagnostiques › Imagerie diagnostique › Tomographie › Imagerie par résonance magnétique › Multimodality Imaging of Prostate Cancer.
Recherchemedicale.com › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Multimodality Imaging of Prostate Cancer.
Recherchemedicale.com › Diagnostic › Techniques et procédures diagnostiques › Imagerie diagnostique › Imagerie multimodale › Multimodality Imaging of Prostate Cancer.
Recherchemedicale.com › Diagnostic › Techniques et procédures diagnostiques › Imagerie diagnostique › Tomographie › Imagerie par résonance magnétique › Imagerie par résonance magnétique multiparamétrique › Multimodality Imaging of Prostate Cancer.
Recherchemedicale.com › États, signes et symptômes pathologiques › Processus pathologiques › Processus néoplasiques › Métastase tumorale › Multimodality Imaging of Prostate Cancer.
Recherchemedicale.com › États, signes et symptômes pathologiques › Processus pathologiques › Processus néoplasiques › Récidive tumorale locale › Multimodality Imaging of Prostate Cancer.
Recherchemedicale.com › Diagnostic › Pronostic › Stadification tumorale › Multimodality Imaging of Prostate Cancer.
Recherchemedicale.com › Diagnostic › Techniques et procédures diagnostiques › Techniques de diagnostic radioisotopique › Scintigraphie › Tomoscintigraphie › Tomographie par émission de positons › Tomographie par émission de positons couplée à la tomodensitométrie › Multimodality Imaging of Prostate Cancer.
Recherchemedicale.com › Diagnostic › Techniques et procédures diagnostiques › Techniques de diagnostic radioisotopique › Scintigraphie › Tomoscintigraphie › Tomographie par émission de positons › Multimodality Imaging of Prostate Cancer.
Recherchemedicale.com › Maladies urogénitales › Tumeurs de l'appareil urogénital › Tumeurs de l'appareil génital mâle › Tumeurs de la prostate › Multimodality Imaging of Prostate Cancer.
Recherchemedicale.com › Maladies urogénitales › Tumeurs de l'appareil urogénital › Tumeurs de l'appareil génital mâle › Tumeurs de la prostate › Tumeurs prostatiques résistantes à la castration › Multimodality Imaging of Prostate Cancer.
Recherchemedicale.com › Diagnostic › Techniques et procédures diagnostiques › Techniques de diagnostic radioisotopique › Scintigraphie › Multimodality Imaging of Prostate Cancer.
Recherchemedicale.com › Technologie, industrie et agriculture › Technologie › Miniaturisation › Nanotechnologie › Nanomédecine › Nanomédecine théranostique › Multimodality Imaging of Prostate Cancer.
Recherchemedicale.com › Diagnostic › Techniques et procédures diagnostiques › Imagerie diagnostique › Tomographie › Tomographie à rayons X › Tomodensitométrie › Multimodality Imaging of Prostate Cancer.
Recherchemedicale.com › Techniques d'investigation › Imagerie du corps entier › Multimodality Imaging of Prostate Cancer.